Improving the External Validity of Conjoint Analysis

What is the impact of changing one treatment attribute on patient preferences for that treatment? This is a key question of interest for many patient preference studies. In practice, this is most often done by estimating the causal effect of changing one attribute of a profile while averaging over the distribution of the remaining profile…

Read More

VBC, MA, FHIR and Modern Care

We know from everyday purchasing of goods and services that you have to combine what you’re getting with what you’re paying for that good or service. But how does this basic consumer supplier concept play out in US healthcare? The post VBC, MA, FHIR and Modern Care appeared first on MedCity News.

Read More

Roche Commits to $50B in U.S. Manufacturing and R&D Investments as Pharma Tariffs Loom

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene therapy and cardiometabolic disease. The plans follow U.S. capital expenditure announcements from several big pharmaceutical companies. The post Roche Commits to $50B in U.S. Manufacturing and R&D Investments as Pharma Tariffs Loom appeared first on…

Read More